Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

300357 • SHE

¥25.82+¥0.82 (3.28%)

Estimate

P/E

31.9

EPS

0.81

Beta

0.38

Growth

Revenue, YoY

10.67%

Net income, YoY

60.38%

FCF, YoY

-11.67%

Forecast

P/E (FWD)

25.3

EPS (FWD)

1.02

Dividends

Dividend yield

1.16%

Annual payout

¥0.30

Next ex. div date

January 9, 27

Payout

12.33%

Div.growth, 5y

4.1%

Dividend growth streak

2 y

Div.rating

About the company

Ticker

300357

ISIN

CNE100001R58

Country

China

Sector (GICS)

Healthcare

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of diagnostic and therapeutic products for allergic diseases in China and internationally. The company offers Changdi, a skin prick test product and dust mite drops; Changhao, an Artemisia annua pollen allergen sublingual drop; and Changdian, a dust mite skin prick test diagnostic kit. It is also involved in the research and development of cells and natural medicines. The company was founded in 2002 and is headquartered in Huzhou, China.

Frequently asked questions

What sector does Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) operate in?

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) current stock price?

As of the latest data, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock price is CN¥25.82, with a previous close of CN¥25.00. Zhejiang Wolwo Bio-Pharmaceutical Co Ltd gained CN¥0.82 in the last trading session, representing a 3.28% increase.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) current market capitalization?

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd market cap is approximately 13.52 billion.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.81, and the forward EPS is CN¥1.02.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) Price-to-Earnings (P/E) ratio?

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd current P/E ratio is 31.88, with a forward P/E of 25.31.

Does Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) pay dividends?

Yes. Zhejiang Wolwo Bio-Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 1.16% and an estimated annual payout of CN¥0.30 per share.

When is the next ex-dividend date for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357)?

The next ex-dividend date is scheduled for January 09, 2027.

What is Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) beta (volatility) score?

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd has a beta of 0.380, indicating lower volatility than the overall market.